Financial News
Latest News about BMY
Recent news which mentions BMY
From Benzinga
‘So bad, it’s good.’ This beleaguered stock market has one big asset on its side, say strategists.
April 29, 2022
From MarketWatch
From Benzinga
Earnings Scheduled For April 29, 2022
April 29, 2022
From Benzinga
7 Stocks To Watch For April 29, 2022
April 29, 2022
From Benzinga
U.S. FDA Approves Bristol Myers Squibb's Camzyos™ (mavacamten) for the Treatment of Adults With obstructive HCM
April 28, 2022
Tickers
BMY
From Benzinga
3 Soaring Warren Buffett Stocks You Can Buy for $76 or Less
April 26, 2022
From Motley Fool
3 Warren Buffett Dividend Stocks You Can Buy Right Now
April 25, 2022
From Motley Fool
From Benzinga
3 Dividend Stocks You Can Buy and Hold for Decades
April 23, 2022
From Motley Fool
Pfizer: What Comes After the Covid-19 Fire?
April 21, 2022
From InvestorPlace
From Benzinga
From Motley Fool
Missed Intuitive Surgical? Buy This Stock Instead
April 20, 2022
From Motley Fool
Why Nektar Therapeutics Stock Is Crashing Today
April 18, 2022
From Motley Fool
Benzinga's Daily Brief On Trending Tickers For April 18, 2022: Casa Systems, Twitter, DiDi Global, And More
April 18, 2022
From Benzinga
From Benzinga
From MarketWatch
2 Unstoppable Green Flags for AbbVie
April 14, 2022
From Motley Fool
10 Health Care Stocks Whale Activity In Today's Session
April 12, 2022
From Benzinga
3 Soaring Pharma Stocks -- Can They Keep Climbing?
April 12, 2022
From Motley Fool
Bristol Myers' Neoadjuvant Opdivo/Chemo Improves Event-Free Survival In Early-Stage Lung Cancer Patients
April 11, 2022
Tickers
BMY
From Benzinga
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.